Hypermarcas (OTCMKTS:HYPMY) Sees Large Decline in Short Interest

Hypermarcas (OTCMKTS:HYPMY) was the target of a significant drop in short interest during the month of February. As of February 13th, there was short interest totaling 16 shares, a drop of 100.0% from the January 29th total of 50,686 shares. Based on an average daily trading volume, of 90,351 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 90,351 shares, the days-to-cover ratio is currently 0.0 days.

Hypermarcas Stock Performance

Shares of OTCMKTS HYPMY traded down $0.02 during trading on Thursday, reaching $4.48. 1,859 shares of the stock traded hands, compared to its average volume of 20,320. The company has a 50-day moving average of $4.48 and a 200-day moving average of $4.42. Hypermarcas has a 52-week low of $3.10 and a 52-week high of $5.50. The stock has a market capitalization of $2.84 billion, a P/E ratio of 19.48 and a beta of 0.71. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.